Accessibility Menu
 
Arrow-Thin-Down
S&P 500
7,337.11
-0.4%
-28.01
Arrow-Thin-Down
DJI
49,596.97
-0.6%
-313.62
Arrow-Thin-Down
NASDAQ
25,806.20
-0.1%
-32.75
Arrow-Thin-Down
Bitcoin
$79,849.00
-1.3%
-$1,025.07
Arrow-Thin-Down
AAPL
$287.40
-0.0%
-$0.11
Arrow-Thin-Down
AMZN
$271.14
-1.4%
-$3.85
Arrow-Thin-Down
GOOG
$395.33
+0.0%
+$0.19
Arrow-Thin-Down
META
$616.81
+0.6%
+$3.93
Arrow-Thin-Down
MSFT
$420.96
+1.7%
+$7.00
Arrow-Thin-Down
NVDA
$211.56
+1.8%
+$3.73
Arrow-Thin-Down
TSLA
$411.25
+3.1%
+$12.52
Most Active StocksDaily Stock GainersDaily Stock Losers
Genprex logo

Genprex

(NASDAQ) GNPX

Current Price$0.86
Market Cap$7.96M
Since IPO (2018)-100%
5 Year-100%
1 Year-94%
1 Month-37%

Genprex Financials at a Glance

Market Cap

$7.96M

Revenue (TTM)

$0.00

Net Income (TTM)

$16.23M

EPS (TTM)

$-27.60

P/E Ratio

-0.03

Dividend

$0.00

Beta (Volatility)

1.21 (Average)

Price

$0.86

Volume

2,217

Open

$0.89

Previous Close

$0.86

Daily Range

$0.86 - $0.90

52-Week Range

$0.86 - $55.00

GNPX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Genprex

Industry

Biotechnology

Sector

Health Care

Employees

13

CEO

Ryan M. Confer

Website

www.genprex.com

Headquarters

Austin, TX 78746, US

GNPX Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-339%

Return on Capital

-2%

Return on Assets

-2%

Earnings Yield

-33.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.96M

Shares Outstanding

9.21M

Volume

2.22K

Avg. Volume

918.54K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$15.52M

EBITDA

$15.49M

Operating Cash Flow

$15.31M

Capital Expenditure

$0.00

Free Cash Flow

$15.31M

Cash & ST Invst.

$7.83M

Total Debt

$0.00

Genprex Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$7.96M

N/A

Market Cap/Employee

$530.85K

N/A

Employees

15

N/A

Net Income

$3.79M

+12.5%

EBITDA

$3.51M

+19.0%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$7.83M

+388.9%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.60%

N/A

Return on Invested Capital

-1.94%

N/A

Free Cash Flow

$4.10M

-5.9%

Operating Cash Flow

$4.10M

-5.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LIMNLiminatus Pharma, Inc. Class A Common Stock
$0.20-2.20%
CMMBChemomab Therapeutics Ltd.
$1.74-2.79%
BIVIBioVie Inc.
$1.54-7.23%
CNSPCNS Pharmaceuticals, Inc.
$7.10+2.90%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$211.56+0.02%
INTCIntel
$109.59-0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$14.47+0.07%
TSLATesla
$411.25+0.03%

Questions About GNPX

What is the current price of Genprex?

Genprex is trading at $0.87 per share.

What is the 52-week range for Genprex?

Over the past 52 weeks, Genprex has traded between $0.86 and $55.00.

How much debt does Genprex have?

As of the most recent reporting period, Genprex reported total debt of N/A.

How much cash does Genprex have on hand?

Genprex reported $7.83M in cash and cash equivalents in its most recent financial results.

What is Genprex’s dividend yield?

Genprex does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services